ClinicalTrials.Veeva

Menu

Results of Surgical Treatment of the Hepatobiliopancreatic Surgical Unit (HPB)

F

Fundacion Miguel Servet

Status

Enrolling

Conditions

Surgical Procedure, Unspecified
Bile Duct Diseases
Pancreas Disease
Liver Diseases

Treatments

Procedure: Hepatobiliopancreatic surgery

Study type

Observational

Funder types

Other

Identifiers

NCT04556019
CIRUGIA HPB-CHN

Details and patient eligibility

About

The main aims of this study are:

    • to evaluate post-surgical morbidity and mortality outcomes, following the criteria and the definitions from Claven-Dindo and ISGPS international classifications, of the patients operated by the HPB Surgical Unit.
    • to evaluate survival and disease-free survival rates of the patients operated by the HPB Surgical Unit due to tumoral cause.

Enrollment

1,000 estimated patients

Sex

All

Ages

15 to 90 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • All patients operated by the HPB Surgical Unit in the last 10 years (retrospective)
  • All patients being operated by the HPB Surgical Unit from January 2019 onwards who provide inform consent (prospective).

Exclusion criteria

  • Patients not eligible for surgery
  • Patients not interested in taking part in the study

Trial contacts and locations

1

Loading...

Central trial contact

Pablo Sánchez Acedo, MD; Francisco Javier Herrera Cabezón, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems